One million courses of therapeutic drug 'slated for delivery' to Canada this year: Pfizer
Pfizer Canada's Kevin Mohamed joined Power & Politics Monday to discuss the Canadian delivery schedule for Pfizer's COVID-19 therapeutic drug Paxlovid, which received Health Canada approval today.
UP NEXT
NOW PLAYING: other
One million courses of therapeutic drug 'slated for delivery' to Canada this year: Pfizer
cbc.ca
UP NEXT
-
Downton Abbey returns to big screen with A New Era
cbc.ca
-
Stockholm restaurant's CO2-capturing aprons help fuel its own greenhouse
-
Volunteers fight flooding in western Manitoba amid heavy rainfall
-
Lawyer explains the IRCC immigration backlog
-
These students from India desperately want to study in Canada
-
Winnipeggers brave the rain to remember Rebecca Contois
-
Montreal officials investigate suspected monkeypox cases
-
U.K. museum returns sacred regalia, artifacts to Alberta First Nation
-
Calls to address online hate speech after Buffalo mass shooting
-
Prince Charles, Camilla wrap up Canadian tour with focus on reconciliation
-
U.S. scrambles to address baby formula shortage
-
UCP MLAs look ahead to leadership race following Jason Kenney’s resignation
-
Canada bans China’s Huawei from 5G network
-
Cathedral dean climbs 70-metre scaffolding to bless restored cross
-
Former Alberta premier Redford weighs in on Jason Kenney's resignation as UCP leader
-
After 3 years, the Cat is back
